FTC Approves Final Order Preserving Competition in U.S. Markets for an Inhalation Solution and Three Injectable Products
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Pfizer Inc.’s $16 billion acquisition of Hospira, Inc. would likely be anticompetitive...